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Key Points
•OM, osteoblast, and
megakaryocyte interac-
tions regulate HSC
function in the niche.
•OMs differ functionally
and phenotypically from
BM-derived
macrophages.
Networking between hematopoietic stem cells (HSCs) and cells of the hematopoietic niche
is critical for stem cell function and maintenance of the stem cell pool. We characterized
calvariae-resident osteomacs (OMs) and their interaction with megakaryocytes to sustain
HSC function and identified distinguishing properties between OMs and bone marrow
(BM)–derived macrophages. OMs, identified as CD451F4/801 cells, were easily detectable
(3%-5%) in neonatal calvarial cells. Coculture of neonatal calvarial cells with megakaryo-
cytes for 7 days increased OM three- to sixfold, demonstrating that megakaryocytes regulate
OM proliferation. OMs were required for the hematopoiesis-enhancing activity of
osteoblasts, and this activity was augmented by megakaryocytes. Serial transplantation
demonstrated that HSC repopulating potential was best maintained by in vitro cultures
containing osteoblasts, OMs, and megakaryocytes. With or without megakaryocytes,
BM-derived macrophages were unable to functionally substitute for neonatal calvarial
cell–associated OMs. In addition, OMs differentiated into multinucleated, tartrate resistant
acid phosphatase–positive osteoclasts capable of bone resorption. Nine-color flow
cytometric analysis revealed that although BM-derived macrophages and OMs share many
cell surface phenotypic similarities (CD45, F4/80, CD68, CD11b, Mac2, and Gr-1), only a
subgroup of OMs coexpressed M-CSFR and CD166, thus providing a unique profile for OMs.
CD169 was expressed by both OMs and BM-derived macrophages and therefore was not a
distinguishing marker between these 2 cell types. These results demonstrate that OMs
support HSC function and illustrate that megakaryocytes significantly augment the
synergistic activity of osteoblasts and OMs. Furthermore, this report establishes for the first
time that the crosstalk between OMs, osteoblasts, and megakaryocytes is a novel network
supporting HSC function.
Introduction
Maintenance of hematopoietic stem cell (HSC) function is an orchestrated event between multiple cell
types within the hematopoietic niche.1,2 We previously demonstrated that osteoblasts play a major role
in sustaining HSC function and that immature osteoblasts from neonatal calvariae of 2-day-old pups
mediate a robust in vitro hematopoiesis-enhancing activity.3,4 We also showed that this activity is
inversely correlated with osteoblast maturation and the level of CD166 expression4,5 which is a
functional marker of murine and human HSCs and niche competency.6 Our group also demonstrated
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that megakaryocytes can increase osteoblast proliferation in vitro
and in vivo,7-9 thus implicating megakaryocytes, albeit indirectly, in
HSC maintenance. These observations identified critical interac-
tions between osteoblasts and megakaryocytes and offered a
unique experimental model to assess how megakaryocytes impact
HSC function via osteoblasts.
Recently, independent groups have illustrated that megakaryocytes
potentially regulate HSCs through the expression of platelet factor 4,
transforming growth factor–b, or nuclear factor erythroid 2,10-12
although alternative mechanisms have been reported.13 Other cell
types are also involved in the competence of the hematopoietic
niche, including a unique class of CD451F4/801 macrophages
known as osteomacs (OMs) that line the endosteum.14 The loss of
OMs led to the mobilization of HSCs into the periphery, and
the depletion of macrophages was detrimental for the maintenance
of the niche.14 Furthermore, several groups have shown that
macrophages are involved in HSC regulatory networks15-17 and the
production of reactive oxygen species.18 Although bone marrow
(BM)–derived macrophages express F4/80 (in addition to other
markers, including CD45, CD68 [microsialin], CD169, and variable
amounts of CD11b), it is unknown whether BM-derived macro-
phages and OMs (defined as bone-associated CD451F4/801
cells) are similar in phenotype and functional properties.
Recently, we confirmed that freshly isolated neonatal calvarial cells
(NCCs) from 2-day-old pups,3,4 which are a common source of
osteoblasts and osteoblast progenitors (but devoid of measurable
hematopoietic progenitors), also contain a small group of CD451
F4/801 OMs.19 In this study, we show that these OMs increase in
number after culture with megakaryocytes. Interestingly, we also
show that without CD451F4/801 cells, the hematopoietic-
enhancing activity of NCCs is substantially reduced. The presence
of OMs in NCC preparations gave us the opportunity to closely
investigate how OMs cooperate with osteoblasts and megakaryo-
cytes to impact HSC function. Our studies document that CD451
F4/801 cells in NCC preparations are identical to the previously
described OMs14,19,20 and that these cells are critical for the
maintenance of HSC function. Furthermore, we illustrate that
although BM-derived macrophages share many phenotypic prop-
erties with NCC-derived CD451F4/801 cells, these 2 cell types are
phenotypically and functionally different.
Materials and methods
Preparation of fresh NCCs
Fresh NCCs were prepared as previously described.21 Calvariae
from 2- to 3-day-old neonatal mice were pretreated with 10 mM
EDTA in phosphate-buffered saline (PBS) for 30 minutes. Calvariae
were then subjected to sequential collagenase digestions (200 U/mL;
Collagenase, Type 2, Worthington Biochemicals, Lakewood NJ).
Fractions 3 to 5 (collected between 45-60, 60-75, and 75-90
minutes during the digestion) were collected as fresh NCCs and
are referred to as NCCs unless otherwise specified. These cells
are .95% osteoblasts or osteoblast precursors as previously
demonstrated.22
Preparation of fetal liver-derived megakaryocytes
Murine megakaryocytes were prepared from fetal livers as pre-
viously described.21 Fetuses were dissected from pregnant mice at
embryonic day 13-15. The livers were removed, and single-cell
suspensions were made by forcing cells through sequentially
smaller gauge needles (18, 20, and 23 gauge). Cells were washed
twice with Dulbecco’s modified Eagle’s medium (DMEM), 10% fetal
calf serum and then seeded in 100-mL culture dishes (5 fetal livers
per 100-mm dish), in DMEM 10% fetal calf serum containing 1%
murine thrombopoietin. Megakaryocytes were obtained 3 to 5 days
later by separating them from lymphocytes and other cells using a
1-step albumin gradient. The bottom layer was 3% albumin in PBS
(bovine albumin, protease free and fatty acid poor, Serological
Proteins, Inc., Kankakee, IL); the middle layer was 1.5% albumin in
PBS, and the top layer was media containing the cells to be
separated. All of the cells were sedimented through the layers at 1 g
for 40 minutes at room temperature. The megakaryocyte-rich
fraction was collected from the bottom of the tube.
Cell cultures
The cultures described in this article were established in 12-well
culture plates. Cell types were mixed together (as indicated) in each
individual well without the use of transwells or separating membranes.
When indicated, fractions of freshly prepared NCCs were separated
by cell sorting into CD451F4/801 cells (OMs) and CD452F4/802
cells, referred to hereafter as osteoblasts. In some experiments, as
indicated in the figure legends, total NCCs or OMs or osteoblasts
sorted from total NCCs were first cultured with or without
megakaryocytes for 1 week in a-minimum essential medium
(a-MEM). At the end of 1 week, megakaryocytes were removed by
gentle agitation23 and 1000 freshly sorted Lin2 Sca11 Kit1 (LSK)
cells were added. Cultures were then maintained in medium
consisting of a 1:1 mix of Iscove modified Dulbecco medium and
a-MEM supplemented with 10% fetal bovine serum, 1% penicillin/
streptomycin, and 1% L-glutamine and were supplemented with
murine stem cell factor and interleukin-3 (10 ng/mL, Peprotech), IGF1
and TPO (20 ng/mL, Peprotech), and interleukin-6 and Flt3 (25 ng/mL,
Peprotech) as previously reported.3 Cells were harvested 1 week later
for colony-forming unit (CFU) assay and the CFU fold increase was
calculated relative to that obtained from 250 fresh LSK cells.
BM repopulating assay
BoyJ, C57BL/6J, and C57BL/6JXBoyJ F1 mice were bred and
housed at Indiana University School of Medicine. Eight- to 12-week-
old mice were used. Recipients (F1 mice) received 1000 cGy (650
and 350 cGy split dose, 4 hours apart) before IV injection of test cells
in 200 ml PBS. All procedures were approved by the Institutional
Animal Care and Use Committee of the Indiana University School of
Medicine and followedNational Institutes of Health guidelines. Freshly
isolated BoyJ (CD45.1) LSK cells (1000 cells) or the progeny of
1000 LSK cells cultured for 5 days with NCCs or different fractions of
NCCs (as defined above) were co-transplanted with 100 000C57/B6
(CD45.2) competitor cells. Chimerism was assessed monthly. Four
months after the primary transplantation, the BM content of half of a
femur from each primary recipient was transplanted into a lethally
irradiated CD45.2 3 CD45.1 F1 secondary recipient without
competitor cells, and engraftment was assessed monthly. We have
previously demonstrated3 that total NCCs do not contain any
detectable BM-repopulating or clonogenic cells.
Cell staining, flow cytometry, and cell sorting
Cells were washed with stain wash (PBS, 1% bovine calf serum, and
1%penicillin/streptomycin) and stained for 15minutes on ice. Freshly
isolated cells (NCCs, neonatal BM cells, or BM cells from 8-week-old
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mice) were stained with CD45 and F4/80 and sorted (FACSAria or
SORP FACSAria, BD Biosciences) into CD451F4/801 (OMs) and
CD452F4/802 (osteoblasts). Low-density BM cells were stained
with fluorescein isothiocyanate–conjugated lineage anti-mouse
antibodies CD3, CD4, CD45R, Ter119, and Gr1 (BioLegend),
allophycocyanin (APC) c-Kit (CD117, BioLegend), and phycoery-
thrin (PE) Sca-1 (BioLegend) to collect LSK cells by cell sorting. For
the multicolor analysis, cells were stained with a cocktail of Pacific
Blue anti-CD45, APC anti-F4/80, APC/Cy7 anti-CD11b, PerCP/
Cy5.5 anti-CD68, PE/Dazzle 594 anti-Ly-6G, Alexa Fluor 488 anti-
Mac-2, PE/Cy7 anti-macrophage colony-stimulating factor (M-CSF)
receptor, PE anti-CD166, and Brilliant Violent 605 anti-CD169. All
antibodies except anti-CD166 were obtained from BioLegend. Anti-
CD166 was obtained from Invitrogen. Cells were analyzed on a
FACS Fortessa cell analyzer.
Osteoclast differentiation
Murine OMs or BM monocytes (20 000 cells per well) were seeded
in a 96-well plate in a-MEM with 10% fetal bovine serum in the
presence ofM-CSF (20 ng/mL) andRANK ligand (RANKL) (80 ng/mL).
The medium was changed every other day for 5 to 6 days. Once
mature osteoclasts were formed, cells were fixed with 3.7%
formaldehyde in PBS for 15 minutes at room temperature. Cells
were stained for tartrate resistant acid phosphatase (TRAP) using a
kit from Sigma (387A). Osteoclasts, defined as TRAP1 cells with
$3 nuclei were counted. Mature osteoclasts were trypsinized
and cultured on dentin with M-CSF and RANKL. After 3 days,
osteoclasts were removed by mechanical agitation. Dentin slices
were incubated with 20 mg/mL of peroxidase-conjugated wheat
germ agglutinin for 90 minutes. After washing with PBS, 3,39-
diaminobenzidine (Sigma-Aldrich) was added to stain osteoclast
resorption pits. Osteoclasts were imaged using Image-Pro version
7.0 software on a Leica DM1400 inverted epifluorscent microscope
fitted with an automated stage and a Retiga EXi digital camera.
Statistical analysis
Experiments were repeated $3 times. Data are presented as the
mean 6 standard deviation unless otherwise stated. Statistical
differences were determined by Student t test, 1-way analysis of
variance (ANOVA) or 2-way ANOVA with Tukey post-hoc analysis.
Significance was set at P , .05
Results
Consistent with a previous report,24 we identified in freshly isolated
NCCs (which are predominantly CD452) a population of CD451
F4/801 cells that share multiple characteristics with OMs14,19
(Figure 1A; NCC, left dot plot). CD451 cells in NCCs expressed
some classical macrophage markers, but were mostly negative for
others (Figure 1A, NCC). Because megakaryocytes promote in vitro
and in vivo osteoblast expansion,7,9,25 we examined the impact of
megakaryocyte stimulation on NCCs. When cultured alone for
7 days, NCCs increased in number, but the percentage of CD451
cells remained relatively unchanged or declined (Figure 1A; cultured
NCC, left dot plot). However, NCCs cocultured with megakaryocytes
displayed a significant increase in the percentage of CD451 cells
(Figure 1A; cultured NCC1MK, left dot plot), indicating that
megakaryocytes promote CD451 cell proliferation in vitro.
We performed a series of experiments to examine previously
reported14,19,24,26 functional properties of OMs. OMs were
characterized as endosteal macrophages that contribute to
osteoblast mineralization26 and do not differentiate into osteo-
clasts.24 NCC-derived CD451F4/801 cells did not differentiate
into osteoblasts (data not shown). However, the removal of CD451
F4/801 cells from NCCs significantly reduced the ability of the
remaining cells (CD452F4/802 fraction of NCC) to mineralize
(calcium levels of 3.036 0.04 mg/mL for CD452F4/802 cells alone
vs 5.596 0.01 mg/mL for CD452F4/802 cells with OMs; P, .05),
thus confirming previously published observations.20,26 On the
other hand, RANKL and M-CSF induced CD451F4/801 cells to
differentiate into multinucleated osteoclasts that express TRAP
(Figure 1B-C, left micrograph) and were capable of forming dentin
resorption pits (Figure 1C, right micrograph) suggesting that,
contrary to published data,24 NCC-derived CD451F4/801 cells
contain osteoclast progenitors. Furthermore, using our culture
conditions, we established that osteoclast formation was increased
in calvariae-derived OMs compared with BM CD451F4/801 cells
(Figure 1B).
We next examined the phenotypic and functional properties of OMs
contained in NCCs and their CD451F4/801 BM-derived counter-
parts collected from the long bones of neonatal pups. To identify
possible developmental changes in the phenotypic makeup of
BM-derived macrophages, we also analyzed BM cells collected
from the long bones of 8-week-old mice. To confirm that OMs are
osteolineage-associated macrophages (present in the bones of
neonatal and adult mice) with a unique identity, we also analyzed
digested bones (previously flushed) from 8-week-old mice. Figure 2
demonstrates that cells from all 4 sources shared similar profiles for
multiple markers. However, only NCC-derived CD451F4/801 cells
and the enzymatically released CD451F4/801 cells from flushed
8-week long bones contained a distinct subgroup of cells that
coexpressed CD166 and M-CSFR. Double expression of CD166
and M-CSFR was evident among Ly-6G1Mac22 and Ly-6G1
Mac21 cells (Figure 2). Based on fluorescence minus one data
(supplemental Figure 2), BM-derived macrophages and NCCs are
Mac2low (Galectin-3low) as has been reported by others17,26,27
suggesting that Ly-6G1Mac21 cells may in fact be considered
Ly-6G1Mac2low cells. This is in agreement with reports indicating
that tissue resident macrophages (such as OM) are Mac22 or low
as opposed to Mac2high inflammatory macrophages.17 Expression
of other surface markers by OMs and BM-derived macrophages is
shown in supplemental Figure 3. Interestingly, the expression of
CD169 did not discriminate between OMs and BM-derived
macrophages because both groups of cells expressed this marker
(Figure 2). In fact, in the example shown in Figure 2, a higher
percentage of NCCs expressed CD169 than that detected among
neonatal BM cells.
We examined whether BM-derived macrophages can functionally
substitute for OMs to deliver the well-established hematopoiesis-
enhancing activity.3,5 First, we assessed if megakaryocytes can
promote BM-derived CD451F4/801 cells proliferation in vitro as
we demonstrated for OMs (Figure 3A). We cultured NCCs and
megakaryocytes from C57Bl/6J mice (CD45.2) for 1 week with
BM-derived macrophages from BoyJ mice (CD45.1). Megakaryo-
cytes promoted the expansion of OMs, but had no effect on BM
CD451F4/801 macrophages (Figure 3A). Similar results were
obtained when OMs in NCCs were substituted by BM-derived
macrophages (data not shown). These results illustrate that NCC-
derived OMs are a unique class of tissue-resident macrophages
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that display a distinctive response to megakaryocyte stimulation.
We next examined if OMs are essential for the maximal expansion
of CFUs by NCCs. As shown in Figure 3B, megakaryocytes
promoted a significant enhancement of CFU fold increase.
However, regardless of whether megakaryocytes were added to
the cocultures, BM-derived macrophages did not support CFU
fold increase to the same level sustained by OMs, demonstrating
that BM-derived macrophages cannot functionally substitute
for OMs. Osteoblasts alone were capable of expanding CFUs,
but not to the same level as that observed when osteoblasts
were mixed with OMs (Figure 3B). These data demonstrate that
although osteoblasts can mediate the previously reported
hematopoiesis-enhancing activity,3 OMs are required for the
maximal hematopoiesis-enhancing activity promoted by NCCs.
Promotion of the hematopoiesis-enhancing activity was not
restricted to OMs isolated from neonatal calvariae because OMs
collected from the long bones of adult mice mediated the same
activity (supplemental Figure 4). In addition, megakaryocytes
were also able to promote the proliferation of OMs harvested
from the long bones of adult mice (data not shown), illustrating
that the megakaryocyte-mediated enhancement of OM pro-
liferation is not restricted to calvarial OMs only.
Based on the established ability of immature osteoblasts to support
the most robust hematopoiesis-enhancing activity4,5 and the
potential of megakaryocytes to suppress osteoblast differentiation,7
we examined if megakaryocytes can augment the osteoblast-
mediated hematopoiesis-enhancing activity via their interactions
with OMs. Unsorted NCCs, sorted osteoblasts (CD452F4/802), or
OMs from C57BL/6J mice (CD45.2) were used for these assays.
NCCs were cultured fresh (NCC) or were maintained for 1 week
without (1w NCC) or with megakaryocytes (1w NCC1MK) before
their use in culture (Figure 3C). Similarly, we established cultures of
osteoblasts (OB in Figure 3C) and OMs with megakaryocytes
(1w OB1MK and 1w OM1MK, respectively). At the 1-week time
point, cultures were seeded with freshly sorted BoyJ-derived
(CD45.1) LSK cells. Cells were harvested 7 days later and assayed
for CFUs (Figure 3C). Consistent with our previous findings, NCCs
maintained in culture for 1 week (1w NCC) did not provide a
comparable hematopoiesis-enhancing activity relative to fresh
NCCs. Megakaryocytes promoted the hematopoiesis-enhancing
activity of 1w NCC (1w NCC1MK) as evidenced by comparable
CFU counts compared with fresh NCC cultures (Figure 3C).
Interestingly, the megakaryocyte-enhanced activity was lost when
OMs were removed from NCCs by cell sorting (1w OB1MK),
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Figure 1. Phenotypic analysis of fresh and cultured OMs. (A) Representative data from the flow cytometric analysis of freshly isolated NCCs, NCCs cultured alone for
7 days (Cultured NCC), or cultured for 7 days with megakaryocytes (Cultured NCC1MK). In the example shown in the figure, cultures were initiated with 2 3 104 NCCs.
On day 7, cultures contained 7 3 104 cells without and 1.8 3 105 cells with megakaryocytes, indicating that the number of CD451F4/801 cells in these cultures was
;900 and 32 500 on day 7, respectively. Staining included CD41 to ensure that only CD412 cells were analyzed. (B) CD451F/481 OMs from NCCs or BM cells from long
bones were cultured with RANKL and M-CSF to induce osteoclast formation. TRAP1 osteoclasts with $3 nuclei were quantified. *P , .05. (C) Osteoclasts formed from
the calvariae-derived (left panel) OMs were replated on dentin, and resorption pits were stained after 3 days (right panel). Representative images of TRAP1 osteoclasts and
resorption pits formed by these cells are shown. Slides were stained as described in “Materials and methods.” Scale bar indicates 50 mm.
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Figure 2. Phenotypic analysis of OMs and BM-derived macrophages from neonatal and adult donors. Flow cytometric analysis (representative data) of
freshly isolated NCCs, neonatal BM (NBM) cells, digested (after flushing BM) long bones (8-week digested bone) and flushed BM cells (8-week BM) from 8-week-old
mice. An analysis of digested bones and BM from 2 age groups was done to ensure that the identified phenotypes were not confined to a single developmental
stage. Dot plots displaying similarly gated events (top to bottom) containing phenotypically similar cells are shown. Fluorescence minus one (FMO) controls collected
for these assays are shown in supplemental Figure 1. Additional phenotypic data from these analyses are shown in supplemental Figure 3. Please note that
BM-derived macrophages express M-CSFR as expected. However, 2-day– and 8-week–derived BM macrophages do not contain the subgroup of CD1661M-CSFR1
cells.
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suggesting that osteoblasts, OMs, and megakaryocytes cooperate
to promote hematopoietic progenitor and HSC function. Data
depicting the breakdown of the CFU subtypes in these cultures are
shown in supplemental Figure 5.
In vitro observations were validated in competitive repopulation
assays (Figure 4). An illustration depicting the experimental set-up
of these studies is shown in Figure 4A. The kinetics of chimerism
in the peripheral blood of primary recipients over a period of
4 months are shown in Figure 4B. LSK cells maintained for 1 week
in NCC1MK cultures retained the highest level of repopulating
activity relative to fresh LSK cells (Figure 4B-C), suggesting that
megakaryocytes were able to reverse the decline in the
hematopoiesis-enhancing activity of NCCs cultured alone without
megakaryocytes (1w NCC). Secondary transplantation data
(Figure 4D) demonstrated again that 1w NCC cultured with
megakaryocytes (1w NCC1MK) retained a robust hematopoiesis-
enhancing activity relative to LSK cells cultured with NCCs
maintained alone for 1 week. Neither osteoblasts nor OMs alone
sustained the BM repopulating potential of LSK cells, suggesting
that the previously documented hematopoiesis-enhancing activity
of NCCs3 is synergistically mediated by osteoblasts and OMs.
Reconstitution was multilineage (supplemental Figure 6).
Discussion
In this article, we further characterized the osteolineage-associated
macrophages known as OMs and showed that, phenotypically and
functionally, OMs are different than BM-derived macrophages,
defined as CD451F4/801 cells. In performing these studies, it was
crucial to design methodologies that can physically separate BM-
derived macrophages from osteolineage-associated OMs in long
bones from adult mice. This approach was important for 2 reasons.
First, it was critical to demonstrate that OMs exist in the long bones
and that they are not a unique developmental cell type present in
only neonatal calvariae. Our studies expand the phenotypic
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Figure 3. Effect of megakaryocytes on OM function. (A) Representative flow cytometric analysis of OMs and macrophages (MF) cultured for 1 week with
megakaryocytes. NCCs and megakaryocytes were isolated from CD45.2 mice, and BM-derived macrophages and CD451F4/801 cells were collected from CD45.1 mice.
(B) Cocultures of NCC-derived OBs (CD452F4/802 cells) mixed with either the original number of OMs contained in freshly isolated NCCs (OM1OB) or a complimentary
number (equivalent to the original number of OMs in NCCs) of BM-derived CD451F4/801 macrophages (MF1OB) were established. LSK cells were added with or without
MKs, and LSK progeny were assessed for CFU content on day 7. CFU fold increase was calculated relative to that obtained from 250 fresh LSK cells. *P , .001 vs LSK,
OB, MF1OB; 1P , .001 vs MK, OB1MK, MF1OB1MK; 1-way ANOVA). (C) Fresh NCCs or fractions of NCCs (OBs or OMs) cultured with or without MKs (as indicated
on the x-axis) were seeded with LSK cells then assayed 7 days later for their CFU content. CFU fold increase was calculated relative to that obtained from 250 fresh LSK cells.
*P , .05 vs LSK, OM, and OB groups; 1P , .005 vs MK, OM1MK, and OB1MK groups; #P , .05 vs 1w OM1OB and 1wNCC groups; one-way ANOVA). Please note
that data in panels B and C are reported as fold increase rather than absolute numbers of CFUs to highlight the magnitude 1wNCC of CFU increase in these cultures. MK,
megakaryocyte; OB, osteoblast.
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definition previously attributed to these cells and confirm that OMs
are not a developmentally or anatomically unique cell population
(Figure 2). More importantly, our studies also confirm that OMs
collected from the hematopoietic niche of adult mice possess the
same functional properties attributed to neonatal OMs (supple-
mental Figure 4). Second, a reliable and reproducible isolation
protocol that consistently yielded separate preparations of BM-
derived macrophages and OMs from long bones was required to
accurately assess the phenotypic and functional differences
between the 2 cell types. Our protocol described in “Materials
and methods” provided these necessary isolation parameters.
Using this approach coupled with multicolor phenotypic analysis,
we were able to identify key expression differences that separated
BM-associated macrophages from bone-associated OMs. Only
OMs and collagenase-digested long bones contained a group of
OMs that coexpressed M-CSFR and CD166. This group of cells
constituted a very small fraction of OMs (Figure 2), which was not
present among BM-derived macrophages from either neonatal or
adult animals. Whether these cells (or a different subfraction of
OMs) are responsible for the functional properties of OM requires
additional investigations. Because we previously demonstrated that
CD166 is expressed on HSCs and is critical to the competence of
the hematopoietic niche,6 it is possible that OMs contribute to the
fitness of the niche through CD166-CD166 homotypic interactions.
It is not clear at present if these homotypic interactions actually take
place or whether they involve OMs and HSCs.
Our studies suggest that CD169, which was previously shown to
identify a niche macrophage critical to HSC function,15,16 was not a
distinguishing marker between OMs and BM-derived macrophages.
Interestingly, our data demonstrate that BM macrophages, identi-
fied by Chow et al.15 as CD1691 cells, may have also been OMs,
because CD169 is not a discriminatory marker between OMs and
BM-derived macrophages. Therefore, our findings suggest that
previous studies15 in which clodronate was used to eliminate
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Figure 4. In vivo assays of cells maintained in vitro with
NCCs or sorted fractions of NCCs. (A) Schema summariz-
ing the protocol for maintaining LSK cells in cocultures
followed by transplantation of progeny cells into CD45.1/
CD45.2 recipients. (B) Progeny of 1000 LSK cells from
C57BL/6 (CD45.2) mice cocultured for 5 days with each
group of cells identified in panel A were transplanted in a
competitive repopulation assay with 100 000 BoyJ (CD45.1)
cells via tail vein injection in lethally irradiated (split dose of
650 and 350 cGy) CD45.1 3 CD45.2 F1 recipients. Freshly
isolated LSK cells from BoyJ mice were used as control.
Engraftment was assessed in the peripheral blood monthly and
plotted for each group (n 5 8–9 mice per group from 2
independent experiments). *P , .05 vs 1w NCC, 1-way
ANOVA. (C) Chimerism in the BM of primary recipients
(shown in panel B) at 4 months posttransplantation. (D) At
4 months post–primary transplantation, halves of femurs from
primary recipients were transplanted into lethally irradiated
secondary recipients. Chimerism in secondary recipients at
3 months posttransplantation is shown (4 mice per group)
*P , .05 vs LSK group, 1P , .05 vs 1w NCC1MK group,
1-way ANOVA.
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macrophages may have also inadvertently removed OMs (in addition
to macrophages and osteoclasts) and incorrectly attributed the
role of supporting erythropoiesis only to BM-resident macrophages
instead of both macrophages and OMs. Our present findings do
not necessarily contradict those of Chow et al.,15 but clarify the
origin and source of these CD169 cells and their anatomic
association in the hematopoietic niche. It is important, however, to
keep in mind that, at least in the functional assays reported in
this article, BM-derived macrophages which are predominantly
CD1691 could not substitute for osteolineage OMs that are also
predominantly CD1691, suggesting that these 2 cell types are
functionally distinct.
Our current studies confirm many of the previously reported
functional properties of OMs,20,24,26 such as their ability to enhance
osteoblast mineralization. However, in our hands, highly purified
CD451F4/801 OMs from NCCs differentiated into TRAP1 osteo-
clasts that were able to resorb dentin (Figure 1C). Previously, Chang
et al24 reported that OMs did not differentiate into TRAP1
osteoclasts in vitro. Although it remains possible that different OM
subpopulations were used by the different laboratories, carefully
controlled and optimized culture conditions are also necessary to
induce osteoclast differentiation, which could possibly explain the
differing results. Alexander et al26 andChang et al24 also reported the
absence of TRAP1 osteoclasts in the immediate microenvironment of
OMs using the macrophage Fas-induced apoptosis mouse model or
clodronate liposome delivery system. In their assessment, these
authors indicated that bone modeling, rather than remodeling, was
occurring at these sites. However, our findings that OMs contain a
population that can form osteoclasts, provides an alternative expla-
nation, that is, that the reported strategies to inhibit OMs also blocked
osteoclast formation.
In conclusion, this report presents evidence that OMs are bone-
associated macrophages that are phenotypically and functionally
distinct from their BM-derived CD451F4/801 counterparts. These
investigations extended the definition of OMs to osteal macro-
phages that have a unique CD1661M-CSFR1 subgroup that is not
present among BM-derived macrophages. Furthermore, we illus-
trate that OMs are critical for the hematopoiesis-enhancing activity
previously attributed to NCCs3 and that megakaryocytes augment this
activity. These findings describe a unique and new network between
osteoblasts, OMs, and megakaryocytes that maintain HSC function
and demonstrate the importance of OMs in bone health, in sustaining
HSC function, and in maintaining the competence of the hematopoi-
etic niche. Further detailed analyses are required to molecularly define
how these cell types interact together.
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